At present there are three super hot fields for anticancer therapy: Immunotherapy, Antibody-drug conjugate (ADC), PARP inhibitors. Patrys' PAT-DX1 covers both PARPi and ADC, which makes it stand out from the competition and even a potential game changer in the monoclonal antibody therapy field.
At present there are three super hot fields for anticancer...
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $3.399K | 485.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 3120846 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 218873 | 2 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |